jRCT2031230142已完成不适用
An Open-label Study of AJG555 in 1-year-old Patients with Chronic Constipation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 1age old over 至 2age old not（—）
- 性别
- All
入选标准
- •Japanese patients with chronic constipation
- •Patients whose number of spontaneous bowel movements was twice a week or less on average for at least
- •1 month before obtaining informed consent
- •Age: 1 year (when informed consent is obtained)
排除标准
- •Patients with known or suspected organic constipation
- •Patients with megacolon and patients with encopresis
- •Patients with known or suspected slow intestinal transit time constipation, including symptomatic
- •constipation and drug-induced constipation
- •Patients with known or suspected constipation due to defecation disorder
研究者
相似试验
招募中
3 期
An Open-label Study of AJG555 in 1-year-old Patients with Chronic ConstipatioChronic constipationJPRN-jRCT2031230142Takeuchi Yutaka26
已完成
3 期
General Clinical Study of AJG555 in Pediatric Patients With Chronic ConstipationChronic ConstipationNCT02961556EA Pharma Co., Ltd.39
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
3 期
Phase III Clinical Study of AJG522 : Studies of safety and efficacy of AJG522 as a colon preparation agent for colonoscopy - Comparative study with MGV-5Patients scheduled for colonoscopyJPRN-jRCT2080221438Ajinomoto Pharmaceuticals Co., Ltd.
未知
2 期
Phase II study of AJG511 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080222245Ajinomoto Pharmaceuticals Co., Ltd.